>Mercado de gestão de doenças crónicas da Ásia-Pacífico, por tipo (solução e serviços), tipo de solução (solução local, solução baseada na nuvem, baseada na Web), tipo de serviço (serviço educativo, serviço de implementação, serviço de consultoria e outros), tipo de doença (Doenças cardiovasculares (DCV), diabetes, doenças pulmonares obstrutivas crónicas (DPOC), artrite, asma, cancro e outras), utilizador final (prestadores de cuidados de saúde, pagadores de cuidados de saúde, outros), país (China , Coreia do Sul, Japão, Índia, Austrália , Singapura, Malásia, Indonésia, Tailândia, Filipinas, Resto da Ásia-Pacífico) Tendências e previsões da indústria para 2028
Análise e insights de mercado : Mercado de gestão de doenças crónicas da Ásia-Pacífico
Espera-se que o mercado de gestão de doenças crónicas ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 15,8% no período de previsão de 2021 a 2028 e prevê-se que atinja os 14.329,15 milhões de USD até 2028. O aumento da prevalência de doenças crónicas exige soluções e serviços avançados de gestão de doenças crónicas, atuando assim como motor para o crescimento do mercado de Gestão de Doenças Crónicas.
A gestão de doenças crónicas (MDL) consiste em cuidados e apoio contínuos para ajudar os indivíduos afectados por uma condição de saúde crónica com os cuidados médicos, conhecimentos, competências e recursos de que necessitam para uma melhor gestão no dia-a-dia. É fornecido principalmente por vários softwares e serviços. A gestão de doenças crónicas ajuda a reduzir os custos dos cuidados de saúde e a melhorar a qualidade de vida dos indivíduos com condições crónicas, prevenindo ou minimizando os efeitos da doença através de cuidados integrados.
O aumento da população geriátrica e o aumento da prevalência de doenças crónicas atuam como impulsionadores do mercado de Gestão de Doenças Crónicas. A preocupação de segurança com as soluções baseadas na cloud reduz a procura por soluções de gestão de doenças crónicas, o que está a restringir o crescimento do mercado de gestão de doenças crónicas. O aumento dos novos avanços tecnológicos atua como uma oportunidade para o mercado de gestão de doenças crónicas. No entanto, a falta de acessibilidade nos países de baixo e médio rendimento atua como desafio para o crescimento do mercado de Gestão de Doenças Crónicas.
O relatório de mercado de gestão de doenças crónicas fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos. Para compreender a análise e o cenário do mercado de gestão de doenças crónicas, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.
Âmbito do mercado de gestão de doenças crónicas e tamanho do mercado
O mercado de gestão de doenças crónicas é segmentado com base no tipo, tipo de solução, tipo de serviço, indicação de doenças e utilizador final. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
- Com base no tipo, o mercado de gestão de doenças crónicas está segmentado em soluções e serviços . Em 2021, prevê-se que o segmento de soluções domine o mercado de gestão de doenças crónicas devido ao aumento do rendimento per capita dos países asiáticos, especialmente dos países em desenvolvimento da Ásia-Pacífico.
- Com base no tipo de solução, o mercado de gestão de doenças crónicas está segmentado em soluções locais, soluções baseadas na cloud e baseadas na web. Em 2021, prevê-se que o segmento de soluções locais domine o mercado de gestão de doenças crónicas devido ao aumento da procura de soluções avançadas para doenças crónicas.
- Com base no tipo de serviço, o mercado de gestão de doenças crónicas está segmentado em serviços de educação, serviços de implementação, serviços de consultoria e outros. Em 2021, prevê-se que o segmento dos serviços de implementação domine o mercado da gestão de doenças crónicas devido à crescente iniciativa estratégica dos principais intervenientes no mercado.
- Com base na indicação da doença, o mercado de gestão de doenças crónicas está segmentado em doenças cardiovasculares (DCV), diabetes , doenças pulmonares obstrutivas crónicas (DPOC), artrite, asma, cancro e outras. Em 2021, prevê-se que o segmento das doenças cardiovasculares (DCV) domine o mercado de gestão de doenças crónicas devido ao aumento do envelhecimento da população em países como a China e a Índia, o que aumenta a prevalência das doenças cardiovasculares (DCV).
- Com base no utilizador final, o mercado de gestão de doenças crónicas está segmentado em prestadores de cuidados de saúde, pagadores de cuidados de saúde e outros. Em 2021, prevê-se que o segmento dos prestadores de cuidados de saúde domine o mercado da gestão de doenças crónicas devido aos crescentes gastos em cuidados de saúde nos países asiáticos.
Análise a nível de país do mercado de gestão de doenças crónicas
O mercado de gestão de doenças crónicas é analisado e são fornecidas informações sobre o tamanho do mercado por país, tipo, tipo de solução, tipo de serviço, tipo de doença e utilizador final como mencionado acima.
Os países abrangidos no relatório de mercado de gestão de doenças crónicas são a China, Coreia do Sul, Japão, Índia, Austrália, Singapura, Malásia, Indonésia, Tailândia, Filipinas e resto da Ásia-Pacífico.
Espera-se que a China domine o mercado devido ao aumento da prevalência de doenças crónicas e da população geriátrica, juntamente com o aumento do rendimento per capita.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Chronic Disease Management, is Boosting the Market Growth of Chronic Disease Management market.
The chronic disease management market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Chronic Disease Management Market Share Analysis
Chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to chronic disease management market.
The major companies which are dealing in the chronic disease management are Health Catalyst, Cedar Gate Technologies, Koninklijke Philips N.V., WellSky, ZeOmega, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Asia-Pacific Solutions Ltd., NXGN Management, LLCVivify Health, Inc., MINES & Associates, Inc., Casenet, LLC., ExlService Holdings, Inc., cliexa, Inc., ScienceSoft USA Corporation, Allscripts Healthcare LLC, Infosys Limited, Medecision, and IBM Corporation among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the chronic disease management market.
For instance,
- In April 2021, WellSky launched advanced home health visit management solution. The new addition CareInsights Guidance provides actionable visit utilization insights to balance the care quality and patient health improvement. It is predicted that, this solution launch will provide benefits to their patients, staff, and leading to upsurge the sales growth of the company.
- Em dezembro de 2020, a HGS AxisPoint Health (uma subsidiária da Hinduja Global Solutions Ltd.) estabeleceu uma parceria com o Parkland Community Health Plan (PCHP). O principal objetivo desta parceria era prestar serviços de gestão de doenças a cerca de 195.000 beneficiários do Medicaid no norte do Texas. Isto melhorou a presença da empresa no mercado global, levando ao aumento do crescimento das vendas da empresa.
A colaboração, o lançamento de produtos, a expansão do negócio, a atribuição de prémios e reconhecimento, as joint ventures e outras estratégias do player de mercado estão a melhorar a pegada da empresa no mercado de gestão de doenças crónicas, o que também proporciona o benefício para o crescimento do lucro da organização .
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS
5.1 REGULATION IN THE UNITED STATES:
5.2 GOVERNING REGULATIONS:
5.3 CPT CODES:
5.4 PRACTITIONER ELIGIBILITY:
5.5 PATIENT ELIGIBILITY:
5.6 REQUIREMENTS:
5.7 REGULATIONS IN EUROPE:
5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:
5.9 DATA PRIVACY PROTECTION IN EUROPE:
5.1 REGULATIONS IN INDIA:
5.11 RELEVANT ACTS FOR THIS FRAMEWORK:
5.12 DATA PRIVACY PROTECTION IN INDIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 GROWING GERIATRIC POPULATION
6.1.3 RISING PER CAPITA INCOME
6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
6.2 RESTRAINTS
6.2.1 HIGH COST OF SERVICES
6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS
6.3 OPPORTUNITIES
6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 INCREASED REIMBURSEMENT POLICIES
6.3.4 RISING DISEASE MANAGEMENT PROGRAMS
6.4 CHALLENGE
6.4.1 LACK OF ACCESSIBILITY
7 IMPACT OF COVID-19 ON THE ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.4 CONCLUSION
8 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 SOLUTION
8.3 SERVICES
9 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE
9.1 OVERVIEW
9.2 ON PREMISE SOLUTION
9.3 WEB BASED SOLUTION
9.4 CLOUD BASED SOLUTION
10 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE
10.1 OVERVIEW
10.2 IMPLEMENTATION SERVICES
10.3 CONSULTING SERVICES
10.4 EDUCATION SERVICES
10.5 OTHERS
11 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION
11.1 OVERVIEW
11.2 CARDIOVASCULAR DISEASES (CVD)
11.3 DIABETES
11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)
11.5 ASTHMA
11.6 ARTHRITIS
11.7 CANCER
11.8 OTHERS
12 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
12.1 OVERVIEW
12.2 HEALTHCARE PROVIDERS
12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY
12.2.2 DIAGNOSTIC & IMAGING CENTERS
12.2.3 AMBULATORY CARE CENTERS
12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES
12.2.5 OTHERS
12.3 HEALTHCARE PAYERS
12.3.1 PUBLIC PAYERS
12.3.2 PRIVATE PAYERS
12.4 OTHERS
13 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 AUSTRALIA
13.1.4 INDIA
13.1.5 SOUTH KOREA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 IBM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 KONINKLIJKE PHILIPS N.V.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 COGNIZANT
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 ALLSCRIPTS HEALTHCARE, LLC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SOLUTION PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ALTRUISTA HEALTH
16.5.1 COMPANY SNAPSHOT
16.5.2 SOLUTION PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 CASENET, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT & SERVICE PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 CEDAR GATE TECHNOLOGIES
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CLIEXA, INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 SOLUTION PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 EPIC SYSTEMS CORPORATION
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EXLSERVICE HOLDINGS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 HEALTH CATALYST
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 HINDUJA ASIA-PACIFIC SOLUTIONS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 INFOSYS LIMITED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SOLUTION PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 MEDECISION
16.14.1 COMPANY SNAPSHOT
16.14.2 SOLUTION PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MINES & ASSOCIATES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 NXGN MANAGEMENT, LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 PEGASYSTEMS INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SCIENCESOFT USA CORPORATION
16.18.1 COMPANY SNAPSHOT
16.18.2 INDUSTRY PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 TCS HEALTHCARE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 VIVIFY HEALTH, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 WELLSKY
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 ZEOMEGA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tabela
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.
TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS
TABLE 5 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 40 CHINA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 41 CHINA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 42 CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 43 CHINA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 CHINA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 CHINA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 JAPAN SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 48 JAPAN SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 49 JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 50 JAPAN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 JAPAN HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 JAPAN HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 AUSTRALIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 55 AUSTRALIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 56 AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 57 AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 AUSTRALIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 AUSTRALIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 INDIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 62 INDIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 INDIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 INDIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 INDIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 SOUTH KOREA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 69 SOUTH KOREA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 75 SINGAPORE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 76 SINGAPORE SERVICE TYPE IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 77 SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 78 SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 SINGAPORE HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 SINGAPORE HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 81 MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 MALAYSIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 83 MALAYSIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 84 MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 85 MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 MALAYSIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 MALAYSIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 88 THAILAND CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 THAILAND SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 90 THAILAND SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 91 THAILAND CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 92 THAILAND CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 93 THAILAND HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 94 THAILAND HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 95 INDONESIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 96 INDONESIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 97 INDONESIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 98 INDONESIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 99 INDONESIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 INDONESIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 101 INDONESIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 102 PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 103 PHILIPPINES SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 104 PHILIPPINES SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 105 PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 106 PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 107 PHILIPPINES HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 108 PHILIPPINES HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 109 REST OF ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
Lista de Figura
FIGURE 1 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)
FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)
FIGURE 20 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020
FIGURE 21 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020
FIGURE 25 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020
FIGURE 29 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020
FIGURE 33 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020
FIGURE 37 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 41 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 42 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)
FIGURE 45 ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
